Competitive Intelligence Landscape Assessment: Business Models, Structures and Policies

In the constantly evolving and complex biopharma marketplace, the Competitive Intelligence function plays an important role in corporate success by helping organizations anticipate and deploy strategic responses to external threats and opportunities. The structure and policies of a Competitive Intelligence group have a significant impact on its effectiveness.

Best Practices, LLC conducted this landscape assessment using a meta-analysis approach to identify evolutionary insights for Competitive Intelligence business models, structures, policies and use of Centers of Excellence in the biopharmaceutical industry. Insights in this research have been distilled from 10 of Best Practices, LLC’s existing benchmarking studies.

KEY TOPICS

• Consensus definition of competitive intelligence
• Competitive intelligence business models
• Structure analysis
• Using centers of excellence (CoE) to balance efficiency & expertise
• Global structures and policies leading local functions

• Which of the listed statements most closely describes the structure/ operating model for your Competitive Intelligence function?
• General FTE range within different Competitive Intelligence group structures
• How is your company’s Commercial / Marketing function organized?

• Competitive Intelligence Structural Forms: As companies grow larger, Competitive Intelligence often moves closer to internal stakeholders, pulling them into decentralized & hybrid forms.

• Competitive Intelligence Cornerstones: Competitive Intelligence models are built on four cornerstones, evolving from self-service towards more consultative approaches where experienced Competitive Intelligence staff increasingly provide future-focused analysis to inform senior leadership decision-making - Service Level, Staffing, Information Types, and Analytic Perspective.

Best Practices, LLC captured data from ten of its benchmarking studies to conduct a Competitive Intelligence Landscape Assessment for the biopharmaceutical sector.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.